{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:25:28Z","timestamp":1792599928670,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273002"],"award-info":[{"award-number":["82273002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373364"],"award-info":[{"award-number":["82373364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04290-y","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T05:12:01Z","timestamp":1769490721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decorin facilitates T cell-mediated antitumor immunity and augments the efficacy of anti-PD1 immunotherapy"],"prefix":"10.1007","volume":"75","author":[{"given":"Ningqian","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvzhu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"4290_CR1","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen L, Han X (2015) Anti\u2013PD-1\/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest 125:3384\u20133391. https:\/\/doi.org\/10.1172\/JCI80011","journal-title":"J Clin Invest"},{"key":"4290_CR2","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad G, Helmink BA, Sharma P, Wargo JA (2021) Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell 184:5309\u20135337. https:\/\/doi.org\/10.1016\/j.cell.2021.09.020","journal-title":"Cell"},{"key":"4290_CR3","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma P, Goswami S, Raychaudhuri D et al (2023) Immune checkpoint therapy\u2014current perspectives and future directions. Cell 186:1652\u20131669. https:\/\/doi.org\/10.1016\/j.cell.2023.03.006","journal-title":"Cell"},{"key":"4290_CR4","doi-asserted-by":"publisher","first-page":"15633","DOI":"10.1073\/pnas.0402976101","volume":"101","author":"PG Scott","year":"2004","unstructured":"Scott PG, McEwan PA, Dodd CM et al (2004) Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc Natl Acad Sci U S A 101:15633\u201315638. https:\/\/doi.org\/10.1073\/pnas.0402976101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4290_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/joim.12400","volume":"278","author":"A Hultg\u00e5rdh-Nilsson","year":"2015","unstructured":"Hultg\u00e5rdh-Nilsson A, Bor\u00e9n J, Chakravarti S (2015) The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis. J Intern Med 278:447\u2013461. https:\/\/doi.org\/10.1111\/joim.12400","journal-title":"J Intern Med"},{"key":"4290_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.addr.2015.10.016","volume":"97","author":"T Neill","year":"2016","unstructured":"Neill T, Schaefer L, Iozzo RV (2016) Decorin as a multivalent therapeutic agent against cancer. Adv Drug Deliv Rev 97:174\u2013185. https:\/\/doi.org\/10.1016\/j.addr.2015.10.016","journal-title":"Adv Drug Deliv Rev"},{"key":"4290_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s12276-023-01023-y","volume":"55","author":"S Wang","year":"2023","unstructured":"Wang S, Qu Y, Fang X et al (2023) Decorin: a potential therapeutic candidate for ligamentum flavum hypertrophy by antagonizing TGF-\u03b21. Exp Mol Med 55:1413\u20131423. https:\/\/doi.org\/10.1038\/s12276-023-01023-y","journal-title":"Exp Mol Med"},{"key":"4290_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.matbio.2006.04.004","volume":"25","author":"R Droguett","year":"2006","unstructured":"Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E (2006) Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol 25:332\u2013341. https:\/\/doi.org\/10.1016\/j.matbio.2006.04.004","journal-title":"Matrix Biol"},{"key":"4290_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/ejh.12125","volume":"91","author":"IB Kristensen","year":"2013","unstructured":"Kristensen IB, Pedersen L, R\u00f8 TB et al (2013) Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration. Eur J Haematol 91:196\u2013200. https:\/\/doi.org\/10.1111\/ejh.12125","journal-title":"Eur J Haematol"},{"key":"4290_CR10","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1111\/febs.12149","volume":"280","author":"A Morrione","year":"2013","unstructured":"Morrione A, Neill T, Iozzo RV (2013) Dichotomy of decorin activity on the insulin-like growth factor-I system. FEBS J 280:2138\u20132149. https:\/\/doi.org\/10.1111\/febs.12149","journal-title":"FEBS J"},{"key":"4290_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2353\/ajpath.2007.060497","volume":"170","author":"L Schaefer","year":"2007","unstructured":"Schaefer L, Tsalastra W, Babelova A et al (2007) Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin. Am J Pathol 170:301\u2013315. https:\/\/doi.org\/10.2353\/ajpath.2007.060497","journal-title":"Am J Pathol"},{"key":"4290_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0002-9440(10)63447-5","volume":"163","author":"N Nili","year":"2003","unstructured":"Nili N, Cheema AN, Giordano FJ et al (2003) Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Am J Pathol 163:869\u2013878. https:\/\/doi.org\/10.1016\/S0002-9440(10)63447-5","journal-title":"Am J Pathol"},{"key":"4290_CR13","doi-asserted-by":"publisher","first-page":"24242","DOI":"10.1074\/jbc.M110.189365","volume":"286","author":"C Vial","year":"2011","unstructured":"Vial C, Guti\u00e9rrez J, Santander C et al (2011) Decorin interacts with connective tissue growth factor (CTGF)\/CCN2 by LRR12 inhibiting its biological activity. J Biol Chem 286:24242\u201324252. https:\/\/doi.org\/10.1074\/jbc.M110.189365","journal-title":"J Biol Chem"},{"key":"4290_CR14","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1038\/sj.onc.1205595","volume":"21","author":"DS Grant","year":"2002","unstructured":"Grant DS, Yenisey C, Rose RW et al (2002) Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21:4765\u20134777. https:\/\/doi.org\/10.1038\/sj.onc.1205595","journal-title":"Oncogene"},{"key":"4290_CR15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3892\/or.19.6.1533","volume":"19","author":"H Satonaka","year":"2008","unstructured":"Satonaka H, Wakabayashi H, Iino T et al (2008) Decorin suppresses lung metastases of murine osteosarcoma. Oncol Rep 19:1533\u20131539. https:\/\/doi.org\/10.3892\/or.19.6.1533","journal-title":"Oncol Rep"},{"key":"4290_CR16","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200999RR","volume":"37","author":"Y Li","year":"2023","unstructured":"Li Y, Gan L, Lu M et al (2023) HBx downregulated decorin and decorin-derived peptides inhibit the proliferation and tumorigenicity of hepatocellular carcinoma cells. FASEB J 37:e22871. https:\/\/doi.org\/10.1096\/fj.202200999RR","journal-title":"FASEB J"},{"key":"4290_CR17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/sj.onc.1208329","volume":"24","author":"CC Reed","year":"2005","unstructured":"Reed CC, Waterhouse A, Kirby S et al (2005) Decorin prevents metastatic spreading of breast cancer. Oncogene 24:1104\u20131110. https:\/\/doi.org\/10.1038\/sj.onc.1208329","journal-title":"Oncogene"},{"key":"4290_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2001868","volume":"4","author":"R Merline","year":"2011","unstructured":"Merline R, Moreth K, Beckmann J et al (2011) Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal 4:ra75. https:\/\/doi.org\/10.1126\/scisignal.2001868","journal-title":"Sci Signal"},{"key":"4290_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/jcp.2004.023135","volume":"59","author":"J K\u00f6ninger","year":"2006","unstructured":"K\u00f6ninger J, Giese NA, Bartel M et al (2006) The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis. J Clin Pathol 59:21\u201327. https:\/\/doi.org\/10.1136\/jcp.2004.023135","journal-title":"J Clin Pathol"},{"key":"4290_CR20","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1182\/blood.V98.7.2124","volume":"98","author":"J Xaus","year":"2001","unstructured":"Xaus J, Comalada M, Card\u00f3 M et al (2001) Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27Kip1 and p21Waf1. Blood 98:2124\u20132133. https:\/\/doi.org\/10.1182\/blood.V98.7.2124","journal-title":"Blood"},{"key":"4290_CR21","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.4049\/jimmunol.170.9.4450","volume":"170","author":"M Comalada","year":"2003","unstructured":"Comalada M, Card\u00f3 M, Xaus J et al (2003) Decorin reverses the repressive effect of autocrine-produced TGF-\u03b2 on mouse macrophage activation. J Immunol 170:4450\u20134456. https:\/\/doi.org\/10.4049\/jimmunol.170.9.4450","journal-title":"J Immunol"},{"key":"4290_CR22","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.18632\/oncotarget.23869","volume":"9","author":"W Zhang","year":"2018","unstructured":"Zhang W, Ge Y, Cheng Q et al (2018) Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment. Oncotarget 9:5480\u20135491. https:\/\/doi.org\/10.18632\/oncotarget.23869","journal-title":"Oncotarget"},{"key":"4290_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ajpath.2012.04.029","volume":"181","author":"T Neill","year":"2012","unstructured":"Neill T, Schaefer L, Iozzo RV (2012) Decorin: a guardian from the matrix. Am J Pathol 181:380\u2013387. https:\/\/doi.org\/10.1016\/j.ajpath.2012.04.029","journal-title":"Am J Pathol"},{"key":"4290_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/hep.26628","volume":"59","author":"L Zhang","year":"2014","unstructured":"Zhang L, Yang Z, Ma A et al (2014) Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase\/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma. Hepatology 59:178\u2013189. https:\/\/doi.org\/10.1002\/hep.26628","journal-title":"Hepatology"},{"key":"4290_CR25","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1038\/s41467-021-25032-5","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Xu G, Wang B et al (2021) USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade. Nat Commun 12:4852. https:\/\/doi.org\/10.1038\/s41467-021-25032-5","journal-title":"Nat Commun"},{"key":"4290_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118400","volume":"333","author":"R Hu","year":"2024","unstructured":"Hu R, Li J, Huang Q et al (2024) Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes. J Ethnopharmacol 333:118400. https:\/\/doi.org\/10.1016\/j.jep.2024.118400","journal-title":"J Ethnopharmacol"},{"key":"4290_CR27","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","volume":"26","author":"DA Braun","year":"2020","unstructured":"Braun DA, Hou Y, Bakouny Z et al (2020) Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat Med 26:909\u2013918. https:\/\/doi.org\/10.1038\/s41591-020-0839-y","journal-title":"Nat Med"},{"key":"4290_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide TN, Quek C, Menzies AM et al (2019) Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy. Cancer Cell 35:238-255.e6. https:\/\/doi.org\/10.1016\/j.ccell.2019.01.003","journal-title":"Cancer Cell"},{"key":"4290_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"4290_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4049\/jimmunol.2001203","volume":"206","author":"AT Baker","year":"2021","unstructured":"Baker AT, Abuwarwar MH, Poly L et al (2021) Cancer-associated fibroblasts and T cells: from mechanisms to outcomes. J Immunol 206:310\u2013320. https:\/\/doi.org\/10.4049\/jimmunol.2001203","journal-title":"J Immunol"},{"key":"4290_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009111","volume":"12","author":"L Gan","year":"2024","unstructured":"Gan L, Lu T, Lu Y et al (2024) Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8+ T cell infiltration. J ImmunoTher Cancer 12:e009111. https:\/\/doi.org\/10.1136\/jitc-2024-009111","journal-title":"J ImmunoTher Cancer"},{"key":"4290_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0972-8","volume":"18","author":"I-H Ham","year":"2019","unstructured":"Ham I-H, Oh HJ, Jin H et al (2019) Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Mol Cancer 18:68. https:\/\/doi.org\/10.1186\/s12943-019-0972-8","journal-title":"Mol Cancer"},{"key":"4290_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-0272-5","volume":"6","author":"EH Cheteh","year":"2020","unstructured":"Cheteh EH, Sarne V, Ceder S et al (2020) Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells. Cell Death Discov 6:42. https:\/\/doi.org\/10.1038\/s41420-020-0272-5","journal-title":"Cell Death Discov"},{"key":"4290_CR34","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1158\/2159-8290.CD-24-0100","volume":"14","author":"KL Donahue","year":"2024","unstructured":"Donahue KL, Watkoske HR, Kadiyala P et al (2024) Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth. Cancer Discov 14:1964\u20131989. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0100","journal-title":"Cancer Discov"},{"key":"4290_CR35","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen Y, Kim J, Yang S et al (2021) Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell 39:548-565.e6. https:\/\/doi.org\/10.1016\/j.ccell.2021.02.007","journal-title":"Cancer Cell"},{"key":"4290_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002101","volume":"9","author":"J-P Li","year":"2021","unstructured":"Li J-P, Wu C-Y, Chen M-Y et al (2021) PD-1+CXCR5-CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma. J Immunother Cancer 9:e002101. https:\/\/doi.org\/10.1136\/jitc-2020-002101","journal-title":"J Immunother Cancer"},{"key":"4290_CR37","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu G, Zeng Q et al (2024) CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell 42:1370-1385.e9. https:\/\/doi.org\/10.1016\/j.ccell.2024.07.006","journal-title":"Cancer Cell"},{"key":"4290_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109422","volume":"36","author":"AB Rodriguez","year":"2021","unstructured":"Rodriguez AB, Peske JD, Woods AN et al (2021) Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep 36:109422. https:\/\/doi.org\/10.1016\/j.celrep.2021.109422","journal-title":"Cell Rep"},{"key":"4290_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jshs.2024.100991","author":"M Hjorth","year":"2024","unstructured":"Hjorth M, Egan CL, Telles GD et al (2024) Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in mice. J Sport and Health Sci. https:\/\/doi.org\/10.1016\/j.jshs.2024.100991","journal-title":"J Sport and Health Sci"},{"key":"4290_CR40","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jconrel.2015.10.015","volume":"220","author":"Y Na","year":"2015","unstructured":"Na Y, Choi J-W, Kasala D et al (2015) Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model. J Control Release 220:766\u2013782. https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.015","journal-title":"J Control Release"},{"key":"4290_CR41","doi-asserted-by":"publisher","first-page":"35153","DOI":"10.1074\/jbc.M006821200","volume":"275","author":"M Santra","year":"2000","unstructured":"Santra M, Eichstetter I, Iozzo RV (2000) An anti-oncogenic role for decorin: down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells *. J Biol Chem 275:35153\u201335161. https:\/\/doi.org\/10.1074\/jbc.M006821200","journal-title":"J Biol Chem"},{"key":"4290_CR42","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1083\/jcb.200901129","volume":"185","author":"S Goldoni","year":"2009","unstructured":"Goldoni S, Humphries A, Nystr\u00f6m A et al (2009) Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 185:743\u2013754. https:\/\/doi.org\/10.1083\/jcb.200901129","journal-title":"J Cell Biol"},{"key":"4290_CR43","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/sj.gt.3300709","volume":"5","author":"M St\u00e4nder","year":"1998","unstructured":"St\u00e4nder M, Naumann U, Dumitrescu L et al (1998) Decorin gene transfer-mediated suppression of TGF-\u03b2 synthesis abrogates experimental malignant glioma growth in vivo. Gene Ther 5:1187\u20131194. https:\/\/doi.org\/10.1038\/sj.gt.3300709","journal-title":"Gene Ther"},{"key":"4290_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bph.14180","volume":"176","author":"AO Sainio","year":"2019","unstructured":"Sainio AO, J\u00e4rvel\u00e4inen HT (2019) Decorin-mediated oncosuppression - a potential future adjuvant therapy for human epithelial cancers. Br J Pharmacol 176:5\u201315. https:\/\/doi.org\/10.1111\/bph.14180","journal-title":"Br J Pharmacol"},{"key":"4290_CR45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.matbio.2017.10.005","volume":"75\u201376","author":"S Buraschi","year":"2019","unstructured":"Buraschi S, Neill T, Iozzo RV (2019) Decorin is a devouring proteoglycan: remodeling of intracellular catabolism via autophagy and mitophagy. Matrix Biol 75\u201376:260\u2013270. https:\/\/doi.org\/10.1016\/j.matbio.2017.10.005","journal-title":"Matrix Biol"},{"key":"4290_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","volume":"40","author":"G Kroemer","year":"2010","unstructured":"Kroemer G, Mari\u00f1o G, Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40:280\u2013293. https:\/\/doi.org\/10.1016\/j.molcel.2010.09.023","journal-title":"Mol Cell"},{"key":"4290_CR47","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nri2161","volume":"7","author":"B Levine","year":"2007","unstructured":"Levine B, Deretic V (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 7:767\u2013777. https:\/\/doi.org\/10.1038\/nri2161","journal-title":"Nat Rev Immunol"},{"key":"4290_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/cdd.2011.146","volume":"19","author":"D Denton","year":"2012","unstructured":"Denton D, Nicolson S, Kumar S (2012) Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 19:87\u201395. https:\/\/doi.org\/10.1038\/cdd.2011.146","journal-title":"Cell Death Differ"},{"key":"4290_CR49","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nrc2254","volume":"7","author":"R Mathew","year":"2007","unstructured":"Mathew R, Karantza-Wadsworth V, White E (2007) Role of autophagy in cancer. Nat Rev Cancer 7:961\u2013967. https:\/\/doi.org\/10.1038\/nrc2254","journal-title":"Nat Rev Cancer"},{"key":"4290_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:27\u201342. https:\/\/doi.org\/10.1016\/j.cell.2007.12.018","journal-title":"Cell"},{"key":"4290_CR51","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.immuni.2022.09.014","volume":"55","author":"D Denk","year":"2022","unstructured":"Denk D, Petrocelli V, Conche C et al (2022) Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy. Immunity 55:2059-2073.e8. https:\/\/doi.org\/10.1016\/j.immuni.2022.09.014","journal-title":"Immunity"},{"key":"4290_CR52","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"Y-R Yu","year":"2020","unstructured":"Yu Y-R, Imrichova H, Wang H et al (2020) Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion. Nat Immunol 21:1540\u20131551. https:\/\/doi.org\/10.1038\/s41590-020-0793-3","journal-title":"Nat Immunol"},{"key":"4290_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv6902","volume":"11","author":"R Zhang","year":"2025","unstructured":"Zhang R, Gao F, Li J et al (2025) USP30 inhibition augments mitophagy to prevent T cell exhaustion. Sci Adv 11:eadv6902. https:\/\/doi.org\/10.1126\/sciadv.adv6902","journal-title":"Sci Adv"},{"key":"4290_CR54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","volume":"40","author":"E Limagne","year":"2022","unstructured":"Limagne E, Nuttin L, Thibaudin M et al (2022) MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells. Cancer Cell 40:136-152.e12. https:\/\/doi.org\/10.1016\/j.ccell.2021.12.009","journal-title":"Cancer Cell"},{"key":"4290_CR55","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.7150\/thno.78467","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Wang H, Luo J et al (2022) Decorin promotes decidual M1-like macrophage polarization via mitochondrial dysfunction resulting in recurrent pregnancy loss. Theranostics 12:7216\u20137236. https:\/\/doi.org\/10.7150\/thno.78467","journal-title":"Theranostics"},{"key":"4290_CR56","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.18632\/oncotarget.13972","volume":"8","author":"E Oh","year":"2016","unstructured":"Oh E, Choi I-K, Hong J, Yun C-O (2016) Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model. Oncotarget 8:4730\u20134746. https:\/\/doi.org\/10.18632\/oncotarget.13972","journal-title":"Oncotarget"},{"key":"4290_CR57","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1128\/JVI.02565-09","volume":"84","author":"C Cellerai","year":"2010","unstructured":"Cellerai C, Perreau M, Rozot V et al (2010) Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R\u03b1 (CD127) and perforin expression. J Virol 84:3868\u20133878. https:\/\/doi.org\/10.1128\/JVI.02565-09","journal-title":"J Virol"},{"key":"4290_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210540","volume":"14","author":"F Perdomo-Celis","year":"2019","unstructured":"Perdomo-Celis F, Velilla PA, Taborda NA, Rugeles MT (2019) An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression. PLoS ONE 14:e0210540. https:\/\/doi.org\/10.1371\/journal.pone.0210540","journal-title":"PLoS ONE"},{"key":"4290_CR59","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/art.39295","volume":"67","author":"L Cifaldi","year":"2015","unstructured":"Cifaldi L, Prencipe G, Caiello I et al (2015) Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome. Arthritis Rheumatol 67:3037\u20133046. https:\/\/doi.org\/10.1002\/art.39295","journal-title":"Arthritis Rheumatol"},{"key":"4290_CR60","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1158\/0008-5472.CAN-24-0749","volume":"85","author":"J Domagala","year":"2025","unstructured":"Domagala J, Grzywa TM, Baranowska I et al (2025) Ammonia suppresses the antitumor activity of natural killer cells and T cells by decreasing mature perforin. Cancer Res 85:2448\u20132467. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-0749","journal-title":"Cancer Res"},{"key":"4290_CR61","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1182\/blood-2012-07-441832","volume":"122","author":"A Cohnen","year":"2013","unstructured":"Cohnen A, Chiang SC, Stojanovic A et al (2013) Surface CD107a\/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood 122:1411\u20131418. https:\/\/doi.org\/10.1182\/blood-2012-07-441832","journal-title":"Blood"},{"key":"4290_CR62","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1084\/jem.20031799","volume":"199","author":"P Wolint","year":"2004","unstructured":"Wolint P, Betts MR, Koup RA, Oxenius A (2004) Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med 199:925\u2013936. https:\/\/doi.org\/10.1084\/jem.20031799","journal-title":"J Exp Med"},{"key":"4290_CR63","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1073\/pnas.94.8.3926","volume":"94","author":"CS Hirsch","year":"1997","unstructured":"Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z (1997) In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci USA 94:3926\u20133931. https:\/\/doi.org\/10.1073\/pnas.94.8.3926","journal-title":"Proc Natl Acad Sci USA"},{"key":"4290_CR64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.omto.2021.11.018","volume":"24","author":"C Zhang","year":"2022","unstructured":"Zhang C, Fang L, Wang X et al (2022) Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma. Mol Ther Oncolytics 24:14\u201325. https:\/\/doi.org\/10.1016\/j.omto.2021.11.018","journal-title":"Mol Ther Oncolytics"},{"key":"4290_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00883-y","author":"TG Kang","year":"2025","unstructured":"Kang TG, Johnson JT, Zebley CC, Youngblood B (2025) Epigenetic regulation of T cell exhaustion in cancer. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/s41568-025-00883-y","journal-title":"Nat Rev Cancer"},{"key":"4290_CR66","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A (2017) Primary, adaptive and acquired resistance to cancer immunotherapy. Cell 168:707\u2013723. https:\/\/doi.org\/10.1016\/j.cell.2017.01.017","journal-title":"Cell"},{"key":"4290_CR67","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-230238","volume":"42","author":"F Karata\u015f","year":"2025","unstructured":"Karata\u015f F, Acat M, Karatas HG et al (2025) The importance of biglycan, decorin and TGF-1 levels in the diagnosis of non-small cell lung cancer. Cancer Biomark 42:CBM-230238. https:\/\/doi.org\/10.3233\/CBM-230238","journal-title":"Cancer Biomark"},{"key":"4290_CR68","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1002\/ijc.25239","volume":"127","author":"I-C Wu","year":"2010","unstructured":"Wu I-C, Wu D-C, Huang C-C et al (2010) Plasma decorin predicts the presence of esophageal squamous cell carcinoma. Int J Cancer 127:2138\u20132146. https:\/\/doi.org\/10.1002\/ijc.25239","journal-title":"Int J Cancer"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04290-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04290-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04290-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T05:12:02Z","timestamp":1769490722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04290-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4290"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04290-y","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors agree to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The project was conducted following the ethical guidelines (Declaration of Helsinki), and the ethical approval was granted by the Ethics Committee of Renji Hospital, Shanghai Jiao Tong University School of Medicine (EX-2025\u2013007).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"45"}}